The STEP trials, which followed over 4,500 participants, reported depression in fewer than 2% of semaglutide usersa rate similar to placebo groups
Insulin resistance that drives everything forward
This is the only oral GLP-1 that is FDA approved for primary and secondary MACE reduction in adults with T2DM at high risk for these events, including patients with existing heart disease
Work with Boulder Holistic Functional Medicine Curious if GLP-1 therapy is right for you
Operating profit rose by 39.11% to 367.80 crore compared to five years ago, indicating enhanced operational efficiency
Together, we can navigate the complexities of weight management, leveraging cutting-edge science and compassionate care to help you achieve lasting health and rediscover your vitality